|
DK1685839T3
(da)
|
1997-12-22 |
2013-06-24 |
Euro Celtique Sa |
Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
|
|
PT1225897E
(pt)
|
1999-11-01 |
2005-01-31 |
John Rhodes |
Composicao para o tratamento da obstipacao e do sindroma do intestino irritavel
|
|
AU776666B2
(en)
|
2000-02-08 |
2004-09-16 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
US7943173B2
(en)
|
2001-07-18 |
2011-05-17 |
Purdue Pharma L.P. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
US20030157168A1
(en)
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
|
WO2003013525A1
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Opioid agonist formulations with releasable and sequestered antagonist
|
|
CA2478515C
(en)
*
|
2002-04-05 |
2010-09-28 |
Purdue Pharma |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
US7501433B2
(en)
*
|
2002-05-17 |
2009-03-10 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
DK1551372T3
(en)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
|
ATE477268T1
(de)
|
2003-01-28 |
2010-08-15 |
Ironwood Pharmaceuticals Inc |
Zusammensetzungen zur behandlung von magen-darm- störungen
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
HRP20150037T4
(hr)
|
2003-04-08 |
2022-09-02 |
Progenics Pharmaceuticals, Inc. |
Farmaceutske formulacije koje sadrže metilnaltrekson
|
|
JP2006522817A
(ja)
*
|
2003-04-08 |
2006-10-05 |
プロジェニックス ファーマシューティカルズ，インコーポレーテッド |
過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
|
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
|
US8017622B2
(en)
*
|
2003-05-16 |
2011-09-13 |
Jenken Biosciences, Inc. |
Opioid and opioid-like compounds and uses thereof
|
|
ES2314646T3
(es)
*
|
2004-03-22 |
2009-03-16 |
Solvay Pharmaceuticals Gmbh |
Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
|
|
TW200633721A
(en)
*
|
2004-12-14 |
2006-10-01 |
Shionogi & Co |
A pharmaceutical composition for treating constipation
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
CN101171010B
(zh)
|
2005-03-07 |
2014-09-17 |
芝加哥大学 |
阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途
|
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
HUE031042T2
(en)
*
|
2005-07-29 |
2017-06-28 |
Abbott Laboratories Gmbh |
Methods for producing pancreatin powder with low viral content
|
|
US11266607B2
(en)
*
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
|
US9198871B2
(en)
*
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
|
EP1931316B2
(en)
*
|
2005-08-15 |
2017-02-22 |
Abbott Laboratories GmbH |
Controlled release pharmaceutical compositions for acid labile drugs
|
|
US20070185145A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Royds Robert B |
Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
|
|
AU2007240873A1
(en)
*
|
2006-04-19 |
2007-11-01 |
Jill P. Smith |
Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists
|
|
US10072256B2
(en)
*
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
KR101486228B1
(ko)
|
2006-06-19 |
2015-01-26 |
알파마 파머슈티컬스 엘엘씨 |
약제학적 조성물
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
TW200817048A
(en)
*
|
2006-09-08 |
2008-04-16 |
Wyeth Corp |
Dry powder compound formulations and uses thereof
|
|
US20100048519A1
(en)
*
|
2006-09-13 |
2010-02-25 |
Chyon-Hwa Yeh |
Methods of treatment for ulcerative colitis using aminosalicylate
|
|
AU2006348180A1
(en)
*
|
2006-09-13 |
2008-03-20 |
Warner Chilcott Company, Llc |
Methods of treatment for ulcerative colitis
|
|
US8546418B2
(en)
|
2007-03-29 |
2013-10-01 |
Progenics Pharmaceuticals, Inc. |
Peripheral opioid receptor antagonists and uses thereof
|
|
PT2139890E
(pt)
|
2007-03-29 |
2014-09-03 |
Wyeth Llc |
Antagonistas do receptor opióide periférico e respectivas utilizações
|
|
CA2682129A1
(en)
|
2007-03-29 |
2008-10-09 |
Progenics Pharmaceuticals, Inc. |
Crystal forms and uses thereof
|
|
MX2009013293A
(es)
|
2007-06-04 |
2010-02-15 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
|
US8883817B2
(en)
*
|
2007-10-18 |
2014-11-11 |
Aiko Biotechnology |
Combination analgesic employing opioid and neutral antagonist
|
|
US20090130063A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Solvay Pharmaceuticals Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
EP2240489A1
(en)
|
2008-02-06 |
2010-10-20 |
Progenics Pharmaceuticals, Inc. |
Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
|
|
EP2278966B1
(en)
|
2008-03-21 |
2019-10-09 |
The University of Chicago |
Treatment with opioid antagonists and mtor inhibitors
|
|
KR20110004425A
(ko)
*
|
2008-05-07 |
2011-01-13 |
넥타르 테라퓨틱스 |
말초적 작용 오피오이드 길항제의 경구 투여
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
CA2676881C
(en)
|
2008-09-30 |
2017-04-25 |
Wyeth |
Peripheral opioid receptor antagonists and uses thereof
|
|
WO2018129556A1
(en)
|
2017-01-09 |
2018-07-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
KR20170091783A
(ko)
|
2008-12-31 |
2017-08-09 |
알데릭스, 인코포레이티드 |
체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법
|
|
WO2010103039A1
(en)
|
2009-03-10 |
2010-09-16 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
US20120040009A1
(en)
*
|
2009-04-22 |
2012-02-16 |
Lars Holger Hermann |
Particulate pharmaceutical composition with an opioid and an opioid antagonist
|
|
JP5797655B2
(ja)
*
|
2009-09-18 |
2015-10-21 |
アドラー・コーポレーション |
消化管障害のためのオピオイド受容体アンタゴニストの使用
|
|
NZ603173A
(en)
|
2010-05-10 |
2014-10-31 |
Euro Celtique Sa |
Manufacturing of active-free granules and tablets comprising the same
|
|
WO2011141490A1
(en)
|
2010-05-10 |
2011-11-17 |
Euro-Celtique S.A. |
Combination of active loaded granules with additional actives
|
|
AU2013304812B2
(en)
|
2012-08-21 |
2016-06-09 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
US10376481B2
(en)
|
2012-08-21 |
2019-08-13 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
KR20150046310A
(ko)
*
|
2012-08-29 |
2015-04-29 |
샐릭스 파마슈티컬스 인코포레이티드 |
완화제 조성물 및 변비 및 관련 위장관 질병 및 증상 치료를 위한 방법
|
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
SMT201900386T1
(it)
|
2013-04-12 |
2019-09-09 |
Ardelyx Inc |
Composti nhe3-leganti e metodi per l'inibizione del trasporto di fosfato
|
|
KR20180037074A
(ko)
|
2013-07-23 |
2018-04-10 |
유로-셀티큐 에스.에이. |
장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
|
|
EP3068397A1
(en)
|
2013-11-13 |
2016-09-21 |
Euro-Celtique S.A. |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
|
|
EP3229785A2
(de)
*
|
2014-12-08 |
2017-10-18 |
Develco Pharma Schweiz AG |
Naloxon-monopräparat und mehrschichttablette
|
|
US20160256451A1
(en)
*
|
2015-03-06 |
2016-09-08 |
Develco Pharma Schweiz Ag |
Dosage of naloxone
|
|
WO2016193456A2
(en)
*
|
2015-06-03 |
2016-12-08 |
Develco Pharma Schweiz Ag |
Opioid receptor antagonist for use in treating patients with severe constipation
|
|
US9943513B1
(en)
|
2015-10-07 |
2018-04-17 |
Banner Life Sciences Llc |
Opioid abuse deterrent dosage forms
|
|
US10335405B1
(en)
|
2016-05-04 |
2019-07-02 |
Patheon Softgels, Inc. |
Non-burst releasing pharmaceutical composition
|
|
AU2018205400C1
(en)
|
2017-01-09 |
2026-01-15 |
Ardelyx, Inc. |
Compounds useful for treating gastrointestinal tract disorders
|
|
JP2020505333A
(ja)
|
2017-01-09 |
2020-02-20 |
アルデリックス， インコーポレイテッド |
Ｎｈｅ媒介性アンチポートの阻害薬
|
|
US10335375B2
(en)
|
2017-05-30 |
2019-07-02 |
Patheon Softgels, Inc. |
Anti-overingestion abuse deterrent compositions
|
|
WO2023102491A1
(en)
*
|
2021-12-01 |
2023-06-08 |
Invea Therapeutics, Inc. |
Methods for treating gastrointestinal inflammatory disease
|